Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (301-310 of 385) with videos related to

Pageof 39
Sort By:
Blood|December 25, 2012
PBX3 is an important cofactor of HOXA9 in leukemogenesisZejuan Li, Zhiyu Zhang, Yuanyuan Li, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Leukemia|August 30, 2019
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)Mridul Agrawal, Peggy Schwarz, Benedetto Daniele Giaimo, et al.
Blood|November 2, 2012
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)Peter Paschka, Juan Du, Richard F Schlenk, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 8, 2024
Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancerAnn-Kathrin Fröhlich, Jan Porthun, Khawaja M Talha, et al.
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 15, 2023
Hand grip strength in patients with advanced cancer: A prospective studySara Hadzibegovic, Jan Porthun, Alessia Lena, et al.
Blood Advances|June 25, 2026
Rapid and Reproducible Karyotyping with Long Read Sequencing in AML PatientsMichael Heuser, Anna Dolnik, Isabell Arnhardt, et al.
Blood Advances|April 30, 2021
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutationsMichael Heuser, Bennet Heida, Konstantin Büttner, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitisIoanna Minopoulou, Artur Wilhelm, Fredrik Albach, et al.
Pageof 39

Showing results (301-310 of 385) with videos related to

Sort By:
Pageof 39
Blood|December 25, 2012
PBX3 is an important cofactor of HOXA9 in leukemogenesisZejuan Li, Zhiyu Zhang, Yuanyuan Li, et al.
Frontiers in Neurology|February 6, 2026
The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicityLotta Völker, Leonie Müller-Jensen, Sophia Carl, et al.
Leukemia|August 30, 2019
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)Mridul Agrawal, Peggy Schwarz, Benedetto Daniele Giaimo, et al.
Blood|November 2, 2012
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)Peter Paschka, Juan Du, Richard F Schlenk, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 8, 2024
Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancerAnn-Kathrin Fröhlich, Jan Porthun, Khawaja M Talha, et al.
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 15, 2023
Hand grip strength in patients with advanced cancer: A prospective studySara Hadzibegovic, Jan Porthun, Alessia Lena, et al.
Blood Advances|June 25, 2026
Rapid and Reproducible Karyotyping with Long Read Sequencing in AML PatientsMichael Heuser, Anna Dolnik, Isabell Arnhardt, et al.
Blood Advances|April 30, 2021
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutationsMichael Heuser, Bennet Heida, Konstantin Büttner, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitisIoanna Minopoulou, Artur Wilhelm, Fredrik Albach, et al.
Pageof 39